Malaria Drug and Vaccine Research – Bill & Melinda Gates Foundation
Malaria Clinical Trials Alliance is supported by new $17-million Bill & Melinda Gates Foundation grant.
ACCRA, Ghana –- The international INDEPTH Network announced today the establishment of a new initiative, the Malaria Clinical Trials Alliance (MCTA), that will help conduct clinical trials of new drugs and vaccines to fight malaria, a disease that kills 2,000 African children every day.
MCTA will provide training and technical assistance to research centers in nine countries across Africa (Mozambique, Tanzania, Malawi, Gabon, Nigeria, Ghana, The Gambia, Kenya and Senegal) and help to leverage the capabilities of the INDEPTH Network to strengthen global research and development activities targeting malaria. MCTA is supported by a new US$17-million grant from the Bill & Melinda Gates Foundation.
To read the full press release, visit the INDEPTH Web site.